126 related articles for article (PubMed ID: 9338468)
1. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women.
Fitzpatrick AL; Daling JR; Furberg CD; Kronmal RA; Weissfeld JL
Cancer; 1997 Oct; 80(8):1438-47. PubMed ID: 9338468
[TBL] [Abstract][Full Text] [Related]
2. Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study.
Azoulay L; Soldera S; Yin H; Bouganim N
Epidemiology; 2016 Jul; 27(4):594-601. PubMed ID: 27031042
[TBL] [Abstract][Full Text] [Related]
3. Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women.
Wilson LE; D'Aloisio AA; Sandler DP; Taylor JA
Breast Cancer Res; 2016 Jul; 18(1):61. PubMed ID: 27378129
[TBL] [Abstract][Full Text] [Related]
4. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
[TBL] [Abstract][Full Text] [Related]
5. Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.
Raebel MA; Zeng C; Cheetham TC; Smith DH; Feigelson HS; Carroll NM; Goddard K; Tavel HM; Boudreau DM; Shetterly S; Xu S
Am J Epidemiol; 2017 Feb; 185(4):264-273. PubMed ID: 28186527
[TBL] [Abstract][Full Text] [Related]
6. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer.
Meier CR; Derby LE; Jick SS; Jick H
Arch Intern Med; 2000 Feb; 160(3):349-53. PubMed ID: 10668837
[TBL] [Abstract][Full Text] [Related]
8. Association between calcium channel blockers and breast cancer: a meta-analysis of observational studies.
Chen Q; Zhang Q; Zhong F; Guo S; Jin Z; Shi W; Chen C; He J
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):711-8. PubMed ID: 24829113
[TBL] [Abstract][Full Text] [Related]
9. Postdiagnostic Calcium Channel Blocker Use and Breast Cancer Mortality: A Population-based Cohort Study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Epidemiology; 2018 May; 29(3):407-413. PubMed ID: 29608546
[TBL] [Abstract][Full Text] [Related]
10. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic drug usage and prostate cancer: a population-based cohort study.
Kao LT; Huang CC; Lin HC; Huang CY
Asian J Androl; 2018; 20(1):37-42. PubMed ID: 28857052
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive medication use and incident breast cancer in women.
Devore EE; Kim S; Ramin CA; Wegrzyn LR; Massa J; Holmes MD; Michels KB; Tamimi RM; Forman JP; Schernhammer ES
Breast Cancer Res Treat; 2015 Feb; 150(1):219-29. PubMed ID: 25701121
[TBL] [Abstract][Full Text] [Related]
14. Use of antihypertensive medications and breast cancer risk.
Saltzman BS; Weiss NS; Sieh W; Fitzpatrick AL; McTiernan A; Daling JR; Li CI
Cancer Causes Control; 2013 Feb; 24(2):365-71. PubMed ID: 23224328
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk and mortality in users of calcium channel blockers. A cohort study.
Sørensen HT; Olsen JH; Mellemkjaer L; Marie A; Steffensen FH; McLaughlin JK; Baron JA
Cancer; 2000 Jul; 89(1):165-70. PubMed ID: 10897013
[TBL] [Abstract][Full Text] [Related]
16. Use of Antihypertensive Medications and Survival Rates for Breast, Colorectal, Lung, or Stomach Cancer.
Cui Y; Wen W; Zheng T; Li H; Gao YT; Cai H; You M; Gao J; Yang G; Zheng W; Xiang YB; Shu XO
Am J Epidemiol; 2019 Aug; 188(8):1512-1528. PubMed ID: 31062847
[TBL] [Abstract][Full Text] [Related]
17. A cohort study of antihypertensive medication use and breast cancer among Danish women.
Fryzek JP; Poulsen AH; Lipworth L; Pedersen L; Nørgaard M; McLaughlin JK; Friis S
Breast Cancer Res Treat; 2006 Jun; 97(3):231-6. PubMed ID: 16791484
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.
Mullooly M; Khodr ZG; Dallal CM; Nyante SJ; Sherman ME; Falk R; Liao LM; Love J; Brinton LA; Gierach GL
Am J Epidemiol; 2017 Dec; 186(12):1329-1340. PubMed ID: 28637226
[TBL] [Abstract][Full Text] [Related]
19. Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk.
Pedersen GS; Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
Breast Cancer Res Treat; 2010 Jul; 122(1):199-210. PubMed ID: 19949857
[TBL] [Abstract][Full Text] [Related]
20. Preadmission Use of Calcium Channel Blocking Agents Is Associated With Improved Outcomes in Patients With Sepsis: A Population-Based Propensity Score-Matched Cohort Study.
Lee CC; Lee MG; Lee WC; Lai CC; Chao CC; Hsu WH; Chang SS; Lee M
Crit Care Med; 2017 Sep; 45(9):1500-1508. PubMed ID: 28658023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
